Literature DB >> 25435053

HPV transmission in adolescent men who have sex with men.

Noel T Brewer1, William A Calo1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25435053      PMCID: PMC4347870          DOI: 10.1016/S1473-3099(14)71019-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  12 in total

1.  Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis.

Authors:  Jane J Kim
Journal:  Lancet Infect Dis       Date:  2010-11-02       Impact factor: 25.071

Review 2.  EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.

Authors:  Anna R Giuliano; Alan G Nyitray; Aimée R Kreimer; Christine M Pierce Campbell; Marc T Goodman; Staci L Sudenga; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2014-07-26       Impact factor: 7.396

3.  The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia.

Authors:  Megan A Smith; Jie-Bin Lew; Robert J Walker; Julia M L Brotherton; Carolyn Nickson; Karen Canfell
Journal:  Vaccine       Date:  2011-03-17       Impact factor: 3.641

4.  Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.

Authors:  Huachun Zou; Sepehr N Tabrizi; Andrew E Grulich; Jane S Hocking; Catriona S Bradshaw; Alyssa M Cornall; Andrea Morrow; Garrett Prestage; Matthew G Law; Suzanne M Garland; Marcus Y Chen; Christopher K Fairley
Journal:  Lancet Infect Dis       Date:  2014-11-28       Impact factor: 25.071

5.  Meta-analysis of human papillomavirus infection concordance.

Authors:  Paul L Reiter; William F Pendergraft; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-10       Impact factor: 4.254

6.  Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men.

Authors:  Stephen Goldstone; Joel M Palefsky; Anna R Giuliano; Edson D Moreira; Carlos Aranda; Heiko Jessen; Richard J Hillman; Daron G Ferris; Francois Coutlee; Kai-Li Liaw; J Brooke Marshall; Xuehong Zhang; Scott Vuocolo; Eliav Barr; Richard M Haupt; Dalya Guris; Elizabeth I O Garner
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

Review 7.  Epidemiology and pathology of HPV disease in males.

Authors:  Anna R Giuliano; Gabriella Anic; Alan G Nyitray
Journal:  Gynecol Oncol       Date:  2010-02-06       Impact factor: 5.482

8.  Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males.

Authors:  Paul L Reiter; Annie-Laurie McRee; Jessica K Pepper; Melissa B Gilkey; Kayoll V Galbraith; Noel T Brewer
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

9.  What men who have sex with men think about the human papillomavirus vaccine.

Authors:  D Simatherai; C S Bradshaw; C K Fairley; M Bush; S Heley; M Y Chen
Journal:  Sex Transm Infect       Date:  2009-01-19       Impact factor: 3.519

10.  Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1991-11-22
View more
  2 in total

Review 1.  As through a glass, darkly: the future of sexually transmissible infections among gay, bisexual and other men who have sex with men.

Authors:  Mark Richard Stenger; Stefan Baral; Shauna Stahlman; Dan Wohlfeiler; Jerusha E Barton; Thomas Peterman
Journal:  Sex Health       Date:  2017-02       Impact factor: 2.706

Review 2.  Emerging and changing viral diseases in the new millennium.

Authors:  C Scully; L P Samaranayake
Journal:  Oral Dis       Date:  2015-08-06       Impact factor: 3.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.